Vital Therapies Announces Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day losing streak as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Vital Therapies (VTL) Tops Q2 EPS by 3c
August 2, 2016 5:16 PM EDTVital Therapies (NASDAQ: VTL) reported Q2 EPS of ($0.30), $0.03 better than the analyst estimate of ($0.33).
Cash and cash equivalents at June 30, 2016, totaled $73.6 million compared to $83.4 million at December 31, 2015. The Company believes its cash position is sufficient to fund the Company into the first quarter of... More
